Biocartis Group NV
XBRU:BCART

Watchlist Manager
Biocartis Group NV Logo
Biocartis Group NV
XBRU:BCART
Watchlist
Price: 0.29 EUR
Market Cap: 27.2m EUR
Have any thoughts about
Biocartis Group NV?
Write Note

Biocartis Group NV
Interest Income Expense

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Biocartis Group NV
Interest Income Expense Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Interest Income Expense CAGR 3Y CAGR 5Y CAGR 10Y
Biocartis Group NV
XBRU:BCART
Interest Income Expense
-€17m
CAGR 3-Years
-16%
CAGR 5-Years
-58%
CAGR 10-Years
N/A
Nyxoah SA
XBRU:NYXH
Interest Income Expense
€1.5m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Ion Beam Applications SA
XBRU:IBAB
Interest Income Expense
-€2.6m
CAGR 3-Years
29%
CAGR 5-Years
-10%
CAGR 10-Years
N/A
Sequana Medical NV
XBRU:SEQUA
Interest Income Expense
-€3.8m
CAGR 3-Years
-59%
CAGR 5-Years
-20%
CAGR 10-Years
N/A
No Stocks Found

Biocartis Group NV
Glance View

Market Cap
27m EUR
Industry
Health Care

Biocartis Group NV which engages in the development of oncology molecular diagnostic solutions. The company is headquartered in Malines (Mechelen), Antwerpen and currently employs 619 full-time employees. The company went IPO on 2015-04-27. The group has the Idylla system to deliver results within a period of between 35 to 150 minutes.

BCART Intrinsic Value
0.92 EUR
Undervaluation 68%
Intrinsic Value
Price

See Also

What is Biocartis Group NV's Interest Income Expense?
Interest Income Expense
-17m EUR

Based on the financial report for Jun 30, 2023, Biocartis Group NV's Interest Income Expense amounts to -17m EUR.

What is Biocartis Group NV's Interest Income Expense growth rate?
Interest Income Expense CAGR 5Y
-58%

Over the last year, the Interest Income Expense growth was -63%. The average annual Interest Income Expense growth rates for Biocartis Group NV have been -16% over the past three years , -58% over the past five years .

Back to Top